Myriad Genetics Inc. (MYGN)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 0 |
| Ownership rank: | -- |
| % of all portfolios: | 0% |
| History | Portfolio Manager | Activity ▼ | Share change | % change to portfolio | |
| Q1 2017 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Sell 100.00% | 190,720 | 0.04 | |
| Q4 2016 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Add 25.43% | 38,670 | 0.01 | |
| Q3 2016 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Add 61.98% | 58,180 | 0.02 | |
| Q2 2016 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Buy | 93,870 | 0.04 | |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.